BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 8965753)

  • 1. [Lambert-Eaton syndrome].
    Osterhage J; Jost WH; Schimrigk K
    Med Klin (Munich); 1996 Aug; 91(8):526-30. PubMed ID: 8965753
    [No Abstract]   [Full Text] [Related]  

  • 2. [Lambert-Eaton syndrome without calcium channel autoantibodies].
    Delpont E; Martin-Moutot N; Brunetto JL; Desnuelle C
    Rev Neurol (Paris); 1994; 150(3):244-7. PubMed ID: 7863174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Non-neoplastic Lambert-Eaton syndrome. A frequently missed diagnosis?].
    Sieb JP; Dengler R; Jerusalem F
    Nervenarzt; 1992 Apr; 63(4):234-9. PubMed ID: 1317512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lambert-Eaton syndrome and Schwartz-Bartter syndrome in small cell bronchial cancer. Simultaneous manifestation of two paraneoplastic syndromes as an indication of a systemic malignant disease].
    Hennemann B; Lange W; Andreesen R; Mertelsmann R
    Med Klin (Munich); 1993 Jun; 88(6):393-6. PubMed ID: 8393129
    [No Abstract]   [Full Text] [Related]  

  • 5. [Lambert-Eaton myasthenia syndrome--review with case report].
    Engler F
    Fortschr Neurol Psychiatr; 1990 Dec; 58(12):447-54. PubMed ID: 1964928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lambert-Eaton myasthenic syndrome without anti-calcium channel antibody: adverse effect of calcium antagonist diltiazem.
    Ueno S; Hara Y
    J Neurol Neurosurg Psychiatry; 1992 May; 55(5):409-10. PubMed ID: 1318359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Paraneoplastic neurologic syndromes. 2. Lambert-Eaton myasthenic syndrome. 2) Anti-calcium channel antibody and clinical features].
    Nakao Y; Motomura M; Suenaga A; Nakamura T; Yoshimura T; Tsujihata M; Ito M; Kono S; Eguchi K
    Nihon Naika Gakkai Zasshi; 1998 Apr; 87(4):685-90. PubMed ID: 9627478
    [No Abstract]   [Full Text] [Related]  

  • 8. SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.
    Sabater L; Titulaer M; Saiz A; Verschuuren J; Güre AO; Graus F
    Neurology; 2008 Mar; 70(12):924-8. PubMed ID: 18032743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Paraneoplastic neurologic syndromes. 2. Lambert-Eaton myasthenic syndrome. 1) The molecular structure of calcium channel and immunology].
    Komai K; Iwasa K; Takamori M
    Nihon Naika Gakkai Zasshi; 1998 Apr; 87(4):678-84. PubMed ID: 9627477
    [No Abstract]   [Full Text] [Related]  

  • 10. [Lambert-Eaton myasthenic syndrome(LEMS)].
    Inuzuka T
    Ryoikibetsu Shokogun Shirizu; 2000; (29 Pt 4):377-9. PubMed ID: 11031974
    [No Abstract]   [Full Text] [Related]  

  • 11. [Lambert-Eaton myasthenic syndrome].
    Fukunaga H
    Ryoikibetsu Shokogun Shirizu; 2001; (36):354-8. PubMed ID: 11596409
    [No Abstract]   [Full Text] [Related]  

  • 12. Cerebellar ataxia in non-paraneoplastic Lambert-Eaton myasthenic syndrome.
    Lorenzoni PJ; Scola RH; Lang B; Kay CS; Teive HA; Kowacs PA; Werneck LC
    J Neurol Sci; 2008 Jul; 270(1-2):194-6. PubMed ID: 18374949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Paraneoplastic myasthenic syndrome].
    Léger JM; Bachoud-Lévi AC; Eymard B; Théodore C; Bouche P; Pierrot-Deseilligny C
    Rev Neurol (Paris); 1993; 149(8-9):485-8. PubMed ID: 8009147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Atypical paraneoplastic myasthenic syndrome: Lambert-Eaton syndrome or myasthenia?].
    Ferroir JP; Milleron B; Ropert A; Billy C; Nahum L; Tcherakian S; Carette MF
    Rev Pneumol Clin; 1999 Jun; 55(3):168-70. PubMed ID: 10486838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SOX1 autoantibodies: tumor markers in LEMS patients?
    Lang B; Evoli A
    Neurology; 2008 Mar; 70(12):906-7. PubMed ID: 18347313
    [No Abstract]   [Full Text] [Related]  

  • 16. [Muscle weakness as initial symptom of bronchial carcinoma].
    Schlösser NJ; Wokke JH; Lammers JW
    Ned Tijdschr Geneeskd; 1995 Jan; 139(1):27-30. PubMed ID: 7830828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Paraneoplastic Lambert-Eaton syndrome in a patient with disseminated metastatic cancer].
    Arellano-Aguilar G; Núñez-Mojica ES; Gutiérrez-Velazco JL; Domínguez-Carrillo LG
    Cir Cir; 2018; 86(1):79-83. PubMed ID: 29681644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paraneoplastic syndromes affecting the central nervous system.
    Posner JB; Dalmau JO
    Annu Rev Med; 1997; 48():157-66. PubMed ID: 9046952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune disorders of neuromuscular transmission.
    Mahadeva B; Phillips LH; Juel VC
    Semin Neurol; 2008 Apr; 28(2):212-27. PubMed ID: 18351523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The association of the Eaton-Lambert myasthenic syndrome and subacute cerebellar degeneration of nonparaneoplastic origin].
    García Castañón I; Corral I; de Blas G; Fernández Ruiz LC
    Med Clin (Barc); 1995 Mar; 104(8):303-5. PubMed ID: 7700091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.